Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Princess Margaret Hospital is joining Merck's global oncology research network, a group of leading international cancer research institutions working together to develop new cancer drugs faster for patients.
The $17.3-million partnership over five years was announced April 15 at PMH by Ontario's Minister for Research and Innovation, John Milloy, and Merck Canada President Carlos Dourado. The Ontario government investment is $2.6 million through its Biopharmaceutical Investment Program.
Leading the partnership for PMH are Drs. Ben Neel, Director of the Ontario Cancer Institute and the Campbell Family Cancer Research Institute, and Dr. Malcolm Moore, who heads the Department of Medical Oncology and Hematology and the Robert and Maggie Bras and Family New Drug Development Program.
"PMH and Merck are aligned with a passion to find new cancer drugs," said Dr. Moore. "This is exciting and important work to give patients early access to new compounds. We are also asking the question why drugs work in some people, but not others."
Dr. Chris Paige, Vice-President, Research at UHN, said: "The PMH Cancer Program at UHN is pleased to be a partner in this network as it will enable our patients to benefit from early access to innovative treatments."